Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...

The rise in popularity of anti-obesity medications (AOMs), such as popular brand names Ozempic and Wegovy could see a shift ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

Debate over the risks and benefits of the population weight loss drugs like Ozempic, Wegovy, and Zepbound finally came to an ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...

It’s the active ingredient in type 2 diabetes drug Ozempic and the higher-dose obesity drug Wegovy. Since Wegovy’s FDA approval in 2021, Ozempic has often been prescribed off-label for weight ...

He has been vocal in his criticism of Ozempic, which he says is inferior to consuming healthy food, though he recently said such drugs “have a place” in addressing obesity. Mr. Kennedy has ...